A prospective real-world analysis of erenumab in refractory chronic migraine.
Giorgio LambruBethany HillMadeleine MurphyIvona TylovaAnna P AndreouPublished in: The journal of headache and pain (2020)
Erenumab may be an effective and well tolerated therapy for medically refractory CM patients with and without medication overuse.
Keyphrases